dulaglutide vs semaglutide versus once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial Weekly Dulaglutide and Semaglutide clinical

Patent expiration dates for semaglutide and tirzepatide extend several years into the future, making FDA-approved generic versions unlikely until at least the late 2020s

If patients experience persistent gastrointestinal side effects during escalation, the dose can be temporarily reduced or the increase delayed by an additional four weeks

GLP-1 RA medications are carefully designed molecules mimicking the effects of endogenous GLP-1, but they're engineered to remain active in the body for much longer, providing sustained benefits

Modera Clinic & Med Spa offers physician-supervised medical weight loss with semaglutide and tirzepatide at our Frisco, Prosper, and Little Elm locations